Endovascular Treatment of Thoracic Aortic Disease
NCT: NCT00583817 · ENROLLING_BY_INVITATION
NCT IDNCT00583817
StatusENROLLING_BY_INVITATION
Start Date2018-10-25
Completion2030-12
Brief Summary
The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral segment of the aorta (or thoracoabdominal aorta)
Frequently Asked Questions
What is Endovascular Treatment of Thoracic Aortic Disease?
Endovascular Treatment of Thoracic Aortic Disease is a clinical trial registered under NCT00583817. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT00583817?
The current status of NCT00583817 (Endovascular Treatment of Thoracic Aortic Disease) is: ENROLLING_BY_INVITATION.
When did Endovascular Treatment of Thoracic Aortic Disease start?
Endovascular Treatment of Thoracic Aortic Disease started on 2018-10-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.